{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:53:43Z","timestamp":1777658023397,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["Ciencia de Frontera No. 2019-64382"],"award-info":[{"award-number":["Ciencia de Frontera No. 2019-64382"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10787-025-01949-x","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T10:08:27Z","timestamp":1759486107000},"page":"6771-6790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic changes in regulatory immune cells induced by pramipexole and rotigotine: implications for the treatment of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"33","author":[{"given":"Diana Denisse","family":"\u00c1lvarez-Luqu\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adri\u00e1n","family":"Guevara-Salinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Sevilla-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Rosas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Bravo-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria Erandi","family":"P\u00e9rez-Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera Teresa","family":"Vega-Angeles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafne","family":"D\u00edaz-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Castellanos-Barba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1010-698X","authenticated-orcid":false,"given":"Laura","family":"Adalid-Peralta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"1949_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BIOMEDICINES9010047","volume":"9","author":"SI Alam","year":"2021","unstructured":"Alam SI, Jo MG, Park TJ et al (2021) Quinpirole-mediated regulation of dopamine d2 receptors inhibits glial cell-induced neuroinflammation in cortex and striatum after brain injury. Biomedicines 9:1\u201317. https:\/\/doi.org\/10.3390\/BIOMEDICINES9010047","journal-title":"Biomedicines"},{"key":"1949_CR2","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1185\/03007990903364954","volume":"25","author":"S Albrecht","year":"2009","unstructured":"Albrecht S, Buerger E (2009) Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole. Curr Med Res Opin 25:2977\u20132987. https:\/\/doi.org\/10.1185\/03007990903364954","journal-title":"Curr Med Res Opin"},{"key":"1949_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEUROT.2025.E00534","volume":"22","author":"HN Allen","year":"2025","unstructured":"Allen HN, Khanna R (2025) Unveiling the dichotomic nature of VEGFA in neuropathic pain: a path to targeted therapeutics. Neurotherapeutics 22:e00534. https:\/\/doi.org\/10.1016\/J.NEUROT.2025.E00534","journal-title":"Neurotherapeutics"},{"key":"1949_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000501187","volume":"26","author":"A Arce-Sillas","year":"2019","unstructured":"Arce-Sillas A, Sevilla-Reyes E, \u00c1lvarez-Luqu\u00edn DD et al (2019) Expression of dopamine receptors in immune regulatory cells. NeuroImmunoModulation 26:159\u2013166. https:\/\/doi.org\/10.1159\/000501187","journal-title":"NeuroImmunoModulation"},{"key":"1949_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27:27\u201342. https:\/\/doi.org\/10.1111\/ene.14108","journal-title":"Eur J Neurol"},{"key":"1949_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jneuroim.2005.07.013","volume":"169","author":"MJ Besser","year":"2005","unstructured":"Besser MJ, Ganor Y, Levite M (2005) Dopamine by itself activates either D2, D3 or D1\/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNF\u03b1 or both. J Neuroimmunol 169:161\u2013171. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.07.013","journal-title":"J Neuroimmunol"},{"key":"1949_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI36470","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A et al (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119:182\u2013192. https:\/\/doi.org\/10.1172\/JCI36470","journal-title":"J Clin Invest"},{"key":"1949_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611\u2013622. https:\/\/doi.org\/10.1373\/clinchem.2008.112797","journal-title":"Clin Chem"},{"key":"1949_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2020.00187","volume":"14","author":"BB Cao","year":"2020","unstructured":"Cao BB, Zhang XX, Du CY et al (2020) TGF-\u03b21 provides neuroprotection via inhibition of microglial activation in 3-acetylpyridine-induced cerebellar ataxia model rats. Front Neurosci 14:512807. https:\/\/doi.org\/10.3389\/FNINS.2020.00187. (\/BIBTEX)","journal-title":"Front Neurosci"},{"issue":"2","key":"1949_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/S41590-024-02062-X","volume":"26","author":"X Chen","year":"2025","unstructured":"Chen X, Ghanizada M, Mallajosyula V et al (2025) Differential roles of human CD4+ and CD8+ regulatory T cells in controlling self-reactive immune responses. Nat Immunol 26(2):230\u2013239. https:\/\/doi.org\/10.1038\/S41590-024-02062-X","journal-title":"Nat Immunol"},{"key":"1949_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.parkreldis.2018.11.007","volume":"61","author":"M Contin","year":"2019","unstructured":"Contin M, Lopane G, Mohamed S et al (2019) Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 61:111\u2013117. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.11.007","journal-title":"Parkinsonism Relat Disord"},{"key":"1949_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jneuroim.2016.07.008","volume":"298","author":"M Cosentino","year":"2016","unstructured":"Cosentino M, Zaffaroni M, Legnaro M et al (2016) Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis. J Neuroimmunol 298:82\u201389. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.07.008","journal-title":"J Neuroimmunol"},{"key":"1949_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/S40265-015-0377-Y","volume":"75","author":"JP Elshoff","year":"2015","unstructured":"Elshoff JP, Cawello W, Andreas JO et al (2015) An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson\u2019s disease and restless legs syndrome. Drugs 75:487\u2013501. https:\/\/doi.org\/10.1007\/S40265-015-0377-Y","journal-title":"Drugs"},{"key":"1949_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577328","volume":"347","author":"R Espinosa-C\u00e1rdenas","year":"2020","unstructured":"Espinosa-C\u00e1rdenas R, Arce-Sillas A, \u00c1lvarez-Luquin D et al (2020) Immunomodulatory effect and clinical outcome in Parkinsons disease patients on levodopa-pramipexole combo therapy: a two-year prospective study. J Neuroimmunol 347:577328. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577328","journal-title":"J Neuroimmunol"},{"key":"1949_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1082703","author":"F Figueir\u00f3","year":"2016","unstructured":"Figueir\u00f3 F, Muller L, Funk S et al (2016) Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg). Oncoimmunology. https:\/\/doi.org\/10.1080\/2162402X.2015.1082703","journal-title":"Oncoimmunology"},{"key":"1949_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.expneurol.2017.10.001","volume":"298","author":"V Francardo","year":"2017","unstructured":"Francardo V, Schmitz Y, Sulzer D, Cenci MA (2017) Neuroprotection and neurorestoration as experimental therapeutics for Parkinson\u2019s disease. Exp Neurol 298:137\u2013147. https:\/\/doi.org\/10.1016\/j.expneurol.2017.10.001","journal-title":"Exp Neurol"},{"key":"1949_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1469","author":"A Furgiuele","year":"2023","unstructured":"Furgiuele A, Pereira FC, Martini S et al (2023) Dopaminergic regulation of inflammation and immunity in Parkinson\u2019s disease: friend or foe? Clin Transl Immunol. https:\/\/doi.org\/10.1002\/cti2.1469","journal-title":"Clin Transl Immunol"},{"key":"1949_CR18","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1007\/S11033-021-06343-8","volume":"48","author":"H Gao","year":"2021","unstructured":"Gao H, Wang D, Wang YL et al (2021) Pramipexole attenuates 6-OHDA-induced Parkinson\u2019s disease by mediating the Nurr1\/NF-\u03baB pathway. Mol Biol Rep 48:3079\u20133087. https:\/\/doi.org\/10.1007\/S11033-021-06343-8","journal-title":"Mol Biol Rep"},{"key":"1949_CR19","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/BIOINFORMATICS\/BTZ931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Jung D, Yao R (2020) ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36:2628\u20132629. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTZ931","journal-title":"Bioinformatics"},{"key":"1949_CR20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/CELLS11040666","volume":"11","author":"L Ge","year":"2022","unstructured":"Ge L, Liu S, Rubin L et al (2022) research progress on neuroprotection of insulin-like growth factor-1 towards glutamate-induced neurotoxicity. Cells 11:666. https:\/\/doi.org\/10.3390\/CELLS11040666","journal-title":"Cells"},{"key":"1949_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.750542","volume":"12","author":"P Grover","year":"2021","unstructured":"Grover P, Goel PN, Greene MI (2021) Regulatory t cells: regulation of identity and function. Front Immunol 12:750542. https:\/\/doi.org\/10.3389\/FIMMU.2021.750542. (\/XML\/NLM)","journal-title":"Front Immunol"},{"key":"1949_CR22","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1471-4159.2004.02804.x","volume":"91","author":"M Gu","year":"2004","unstructured":"Gu M, Irvani M, Cooper JM et al (2004) Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms. J Neurochem 91:1075\u20131081. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02804.x","journal-title":"J Neurochem"},{"key":"1949_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/CNS.14883","author":"A Guevara-Salinas","year":"2024","unstructured":"Guevara-Salinas A, Netzahualcoyotzi C, \u00c1lvarez-Luqu\u00edn DD et al (2024) Treating activated regulatory T cells with pramipexole protects human dopaminergic neurons from 6-OHDA-induced degeneration. CNS Neurosci Ther. https:\/\/doi.org\/10.1111\/CNS.14883","journal-title":"CNS Neurosci Ther"},{"key":"1949_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11011-024-01463-Z\/METRICS","volume":"40","author":"PC Gurram","year":"2025","unstructured":"Gurram PC, Satarker S, Nassar A et al (2025) Dopamine agonist Rotigotine mitigates lipopolysaccharide-induced neuroinflammation and memory impairment in mice. Metab Brain Dis 40:1\u201312. https:\/\/doi.org\/10.1007\/S11011-024-01463-Z\/METRICS","journal-title":"Metab Brain Dis"},{"key":"1949_CR25","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1159\/000464388","volume":"41","author":"Y Huang","year":"2017","unstructured":"Huang Y, Liu Z, Cao BB et al (2017) Treg cells protect dopaminergic neurons against MPP+ neurotoxicity via CD47-SIRPA interaction. Cell Physiol Biochem 41:1240\u20131254. https:\/\/doi.org\/10.1159\/000464388","journal-title":"Cell Physiol Biochem"},{"key":"1949_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/J.SEMCDB.2023.05.008","volume":"155","author":"S Kaur","year":"2024","unstructured":"Kaur S, Roberts DD (2024) Emerging functions of thrombospondin-1 in immunity. Semin Cell Dev Biol 155:22\u201331. https:\/\/doi.org\/10.1016\/J.SEMCDB.2023.05.008","journal-title":"Semin Cell Dev Biol"},{"key":"1949_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/IMM.13109","volume":"158","author":"A Keren","year":"2019","unstructured":"Keren A, Gilhar A, Ullmann Y et al (2019) Instantaneous depolarization of T cells via dopamine receptors, and inhibition of activated T cells of psoriasis patients and inflamed human skin, by D1-like receptor agonist: fenoldopam. Immunology 158:171. https:\/\/doi.org\/10.1111\/IMM.13109","journal-title":"Immunology"},{"key":"1949_CR28","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","volume":"11","author":"A Kessel","year":"2012","unstructured":"Kessel A, Haj T, Peri R et al (2012) Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun Rev 11:670\u2013677. https:\/\/doi.org\/10.1016\/j.autrev.2011.11.018","journal-title":"Autoimmun Rev"},{"key":"1949_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep33738","volume":"6","author":"N Kustrimovic","year":"2016","unstructured":"Kustrimovic N, Rasini E, Legnaro M et al (2016) Dopaminergic receptors on CD4+ T naive and memory lymphocytes correlate with motor impairment in patients with Parkinson\u2019s disease. Sci Rep 6:1\u201317. https:\/\/doi.org\/10.1038\/srep33738","journal-title":"Sci Rep"},{"key":"1949_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1248-8","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L et al (2018) Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-018-1248-8","journal-title":"J Neuroinflammation"},{"key":"1949_CR31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tins.2023.07.005","volume":"46","author":"J Lauritsen","year":"2023","unstructured":"Lauritsen J, Romero-Ramos M (2023) The systemic immune response in Parkinson\u2019s disease: focus on the peripheral immune component. Trends Neurosci 46:863\u2013878. https:\/\/doi.org\/10.1016\/j.tins.2023.07.005","journal-title":"Trends Neurosci"},{"key":"1949_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/apha.12476","volume":"216","author":"M Levite","year":"2016","unstructured":"Levite M (2016) Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol 216:42\u201389. https:\/\/doi.org\/10.1111\/apha.12476","journal-title":"Acta Physiol"},{"key":"1949_CR33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/CNS.12727","volume":"23","author":"BD Li","year":"2017","unstructured":"Li BD, Bi ZY, Liu JF et al (2017) Adverse effects produced by different drugs used in the treatment of Parkinson\u2019s disease: a mixed treatment comparison. CNS Neurosci Ther 23:827\u2013842. https:\/\/doi.org\/10.1111\/CNS.12727","journal-title":"CNS Neurosci Ther"},{"key":"1949_CR34","doi-asserted-by":"publisher","first-page":"1510897","DOI":"10.3389\/FCELL.2024.1510897\/XML\/NLM","volume":"12","author":"M Li","year":"2024","unstructured":"Li M, Chen M, Li H et al (2024) Glial cells improve Parkinson\u2019s disease by modulating neuronal function and regulating neuronal ferroptosis. Front Cell Dev Biol 12:1510897. https:\/\/doi.org\/10.3389\/FCELL.2024.1510897\/XML\/NLM","journal-title":"Front Cell Dev Biol"},{"key":"1949_CR35","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4103\/1673-5374.253510","volume":"14","author":"P Liu","year":"2019","unstructured":"Liu P, Peng J, Han GH et al (2019) Role of macrophages in peripheral nerve injury and repair. Neural Regen Res 14:1335\u20131342. https:\/\/doi.org\/10.4103\/1673-5374.253510","journal-title":"Neural Regen Res"},{"key":"1949_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS23084148","author":"TW Liu","year":"2022","unstructured":"Liu TW, Chen CM, Chang KH (2022) Biomarker of neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS23084148","journal-title":"Int J Mol Sci"},{"key":"1949_CR37","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.4103\/1673-5374.391181","volume":"19","author":"BM Lozinski","year":"2024","unstructured":"Lozinski BM, Ta K, Dong Y (2024) Emerging role of galectin 3 in neuroinflammation and neurodegeneration. Neural Regen Res 19:2004\u20132009. https:\/\/doi.org\/10.4103\/1673-5374.391181","journal-title":"Neural Regen Res"},{"key":"1949_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/S40364-024-00624-7","volume":"12","author":"H Ma","year":"2024","unstructured":"Ma H, Zhu M, Chen M et al (2024) The role of macrophage plasticity in neurodegenerative diseases. Biomark Res 12:81. https:\/\/doi.org\/10.1186\/S40364-024-00624-7","journal-title":"Biomark Res"},{"key":"1949_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/J.BBI.2020.07.005","volume":"89","author":"L Magistrelli","year":"2020","unstructured":"Magistrelli L, Storelli E, Rasini E et al (2020) Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson\u2019s disease. Brain Behav Immun 89:668\u2013674. https:\/\/doi.org\/10.1016\/J.BBI.2020.07.005","journal-title":"Brain Behav Immun"},{"key":"1949_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0165-5728(02)00280-1","volume":"132","author":"F McKenna","year":"2002","unstructured":"McKenna F, McLaughlin PJ, Lewis BJ et al (2002) Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol 132:34\u201340. https:\/\/doi.org\/10.1016\/S0165-5728(02)00280-1","journal-title":"J Neuroimmunol"},{"key":"1949_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105600","author":"D Misganaw","year":"2021","unstructured":"Misganaw D (2021) Heteromerization of dopaminergic receptors in the brain: pharmacological implications. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2021.105600","journal-title":"Pharmacol Res"},{"key":"1949_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.708874","author":"S Mishra","year":"2021","unstructured":"Mishra S (2021) CD8+ regulatory t cell \u2013 a mystery to be revealed. Front Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2021.708874","journal-title":"Front Immunol"},{"key":"1949_CR43","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.20BR02663","author":"L Murphy","year":"2021","unstructured":"Murphy L, Ly T, Dimario K et al (2021) Treatment of Pramipexole-Induced Problematic Sexual Behaviors. Prim Care Compan CNS Disord. https:\/\/doi.org\/10.4088\/PCC.20BR02663","journal-title":"Prim Care Compan CNS Disord"},{"key":"1949_CR44","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbrc.2008.06.012","volume":"373","author":"K Nakano","year":"2008","unstructured":"Nakano K, Higashi T, Hashimoto K et al (2008) Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun 373:286\u2013291. https:\/\/doi.org\/10.1016\/j.bbrc.2008.06.012","journal-title":"Biochem Biophys Res Commun"},{"key":"1949_CR45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/eji.202048614","volume":"51","author":"V Niederlova","year":"2021","unstructured":"Niederlova V, Tsyklauri O, Chadimova T, Stepanek O (2021) CD8+ Tregs revisited: a heterogeneous population with different phenotypes and properties. Eur J Immunol 51:512\u2013530. https:\/\/doi.org\/10.1002\/eji.202048614","journal-title":"Eur J Immunol"},{"key":"1949_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBIH.2021.100199","volume":"12","author":"MA Penedo","year":"2021","unstructured":"Penedo MA, Rivera-Baltan\u00e1s T, P\u00e9rez-Rodr\u00edguez D et al (2021) The role of dopamine receptors in lymphocytes and their changes in schizophrenia. Brain Behav Immun 12:100199. https:\/\/doi.org\/10.1016\/J.BBIH.2021.100199","journal-title":"Brain Behav Immun"},{"key":"1949_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"1949_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BIOM10071017","volume":"10","author":"C Porro","year":"2020","unstructured":"Porro C, Cianciulli A, Panaro MA (2020) The regulatory role of IL-10 in neurodegenerative diseases. Biomolecules 10:1\u201315. https:\/\/doi.org\/10.3390\/BIOM10071017","journal-title":"Biomolecules"},{"issue":"1","key":"1949_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41531-023-00449-5","volume":"9","author":"Y Qu","year":"2023","unstructured":"Qu Y, Li J, Qin Q et al (2023) A systematic review and meta-analysis of inflammatory biomarkers in Parkinson\u2019s disease. NPJ Parkinsons Dis 9(1):1\u201314. https:\/\/doi.org\/10.1038\/S41531-023-00449-5","journal-title":"NPJ Parkinsons Dis"},{"key":"1949_CR50","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s12035-017-0404-y","volume":"55","author":"NP Rocha","year":"2017","unstructured":"Rocha NP, Assis F, Scalzo PL et al (2017) Reduced activated T lymphocytes (CD4+CD25+) and plasma levels of cytokines in Parkinson\u2019s disease. Mol Neurobiol 55:1488\u20131497. https:\/\/doi.org\/10.1007\/s12035-017-0404-y","journal-title":"Mol Neurobiol"},{"key":"1949_CR51","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","volume":"20","author":"JJ Sabatino","year":"2019","unstructured":"Sabatino JJ, Pr\u00f6bstel A-K, Zamvil SS (2019) B cells in autoimmune and neurodegenerative central nervous system diseases. Nat Rev Neurosci 20:728\u2013745. https:\/\/doi.org\/10.1038\/s41583-019-0233-2","journal-title":"Nat Rev Neurosci"},{"key":"1949_CR52","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00702-019-02115-8","volume":"127","author":"A Salamon","year":"2020","unstructured":"Salamon A, Z\u00e1dori D, Szpisjak L et al (2020) Neuroprotection in Parkinson\u2019s disease: facts and hopes. J Neural Transm 127:821\u2013829. https:\/\/doi.org\/10.1007\/s00702-019-02115-8","journal-title":"J Neural Transm"},{"key":"1949_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/S00210-008-0341-4\/METRICS","volume":"379","author":"D Scheller","year":"2009","unstructured":"Scheller D, Ullmer C, Berkels R et al (2009) The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson\u2019s disease. Naunyn Schmiedebergs Arch Pharmacol 379:73\u201386. https:\/\/doi.org\/10.1007\/S00210-008-0341-4\/METRICS","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1949_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.CGER.2019.08.002","volume":"36","author":"DK Simon","year":"2019","unstructured":"Simon DK, Tanner CM, Brundin P (2019) Parkinson disease epidemiology, pathology, genetics and pathophysiology. Clin Geriatr Med 36:1. https:\/\/doi.org\/10.1016\/J.CGER.2019.08.002","journal-title":"Clin Geriatr Med"},{"key":"1949_CR55","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/MOLECULES30040848","volume":"30","author":"A Spagnoletta","year":"2025","unstructured":"Spagnoletta A, De Palma A, Numakawa T, Kajihara R (2025) The role of brain-derived neurotrophic factor as an essential mediator in neuronal functions and the therapeutic potential of its mimetics for neuroprotection in neurologic and psychiatric disorders. Molecules 30:848. https:\/\/doi.org\/10.3390\/MOLECULES30040848","journal-title":"Molecules"},{"key":"1949_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BRAINSCI10080567","volume":"10","author":"AG Stanfill","year":"2020","unstructured":"Stanfill AG, Cao X (2020) Expression of dopamine-related genes in four human brain regions. Brain Sci 10:1\u201311. https:\/\/doi.org\/10.3390\/BRAINSCI10080567","journal-title":"Brain Sci"},{"key":"1949_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41419-017-0221-2","volume":"9","author":"A Tozzi","year":"2018","unstructured":"Tozzi A, Tantucci M, Marchi S et al (2018) Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson\u2019s disease. Cell Death Dis 9:1\u201313. https:\/\/doi.org\/10.1038\/S41419-017-0221-2","journal-title":"Cell Death Dis"},{"key":"1949_CR58","doi-asserted-by":"crossref","unstructured":"Vandesompele J, De Preter K, Pattyn ilip, et al (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","DOI":"10.1186\/gb-2002-3-7-research0034"},{"key":"1949_CR59","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DAA Vignali","year":"2008","unstructured":"Vignali DAA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8:523\u2013532. https:\/\/doi.org\/10.1038\/nri2343","journal-title":"Nat Rev Immunol"},{"key":"1949_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01427-2","volume":"8","author":"TS Wong","year":"2023","unstructured":"Wong TS, Li G, Li S et al (2023) G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. Signal Transduct Target Ther 8:1\u201357. https:\/\/doi.org\/10.1038\/s41392-023-01427-2","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"1949_CR61","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/S41422-023-00808-0","volume":"33","author":"P Xu","year":"2023","unstructured":"Xu P, Huang S, Krumm BE et al (2023) Structural genomics of the human dopamine receptor system. Cell Res 33(8):604\u2013616. https:\/\/doi.org\/10.1038\/S41422-023-00808-0","journal-title":"Cell Res"},{"key":"1949_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175884","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Chen XT, Chen FF et al (2023) Dopamine agonists versus levodopa monotherapy in early Parkinson\u2019s disease for the potential risks of motor complications: a network meta-analysis. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175884","journal-title":"Eur J Pharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01949-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:03:48Z","timestamp":1763420628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01949-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1949"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01949-x","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: Laura Adalid reports financial support was provided by Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas (CONAHCYT) Mexico. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}